Tuesday, 16th April 2024
To guardian.ng
Search

Factory in northern France on frontline of war against Covid-19

By AFP
13 December 2020   |   11:21 am
A factory run by pharmaceutical group GSK in Saint-Amand-les-Eaux is engaged in a race against time in the fight against Covid-19. It manufactures the adjuvant intended to reinforce the effectiveness of some of the future vaccines. GSK has set itself the goal of producing up to a billion doses of this adjuvant in 2021, several hundred million of which are expected to come out of this northern plant. The remaining doses are produced at GSK sites in Belgium and the United States.

In this article

0 Comments

Your email address will not be published. Required fields are marked *

Related

11 Apr
Some countries in Europe have begun to ban short-haul flights to cut emissions. Will other countries follow? And — can these bans make a real difference?
1 day ago
Here's what's been making the business headlines in sub-Saharan Africa this week.
3 days ago
Nigeria’s Minister of Finance, Wale Edun says 4.83 trillion naira from T-Bills and Bonds issued in the first quarter of this year was used to pay part of the Ways and Means advances from the Central Bank of Nigeria. Sam Chidoka, CEO of Kairos Capital joins CNBC Africa for more on this discussion and Nigeria's debt management strategy.
11 mins ago
A year after Lula came to power, his gamble has paid off: deforestation has been halved in the Amazon. But this success comes at the cost of sacrificing another ecosystem that's just as vital to Brazil: the Cerrado.
2 days ago
France has asked its foreign allies to send several thousand members of their security forces to help guard the Paris Olympics, officials said Thursday, underlining the strains caused by the sporting extravaganza which begins in July.
6 hours ago
Some top Nigerian banks are eyeing the international and local capital markets to raise fresh capital in a bid to meet the recapitalisation exercise by the Central Bank of Nigeria. Egie Akpata, Chairman of Skymark Partners joins CNBC Africa to examine options available to banks.